UNSPSC 85891552: Low dose rate (ldr) brachytherapy of axillary lymphatics using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of axillary lymphatics using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D714B9Z

UNSPSC 85891552 Low dose rate (ldr) brachytherapy of axillary lymphatics using iodine 125 (i-125) is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's taxonomy describes a specialized oncology treatment — low-dose-rate brachytherapy using radioactive iodine for axillary lymphatic applications — yet the single recent state and local opportunity posted under this code solicits temporary health professional staffing services across multiple ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedics, respiratory care, sterile processing, surgical/operating room services, and therapy services. No brachytherapy procurement, radiation oncology services, or iodine-125 supply appears in the available record.

The County of Santa Clara Health System posted RFQ RFSQHHSFY270052 on July 7, 2026, with a response deadline of October 7, 2026, to establish a non-exclusive multiple-award qualified vendor pool for temporary staffing across the clinical categories noted above. The Health System explicitly excludes nursing, physician, and other non-clinical staffing from this solicitation and will negotiate qualifications and scope on a case-by-case basis with selected vendors; placement on the Qualified List carries no guarantee of contract award or work volume, and the list may be maintained for five years. This code shows little relevant recent activity aligned with its brachytherapy taxonomy — the mismatch between code and actual procurement suggests either miscoding on the part of the issuing body or limited state and local demand for the specialized oncology service the code nominally describes.